Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09AHZ
|
|||
| Former ID |
DNCL001864
|
|||
| Drug Name |
Celivarone
|
|||
| Synonyms |
Celivarone; UNII-K45001587E; 401925-43-7; K45001587E; Celivarone [INN]; SSR 149744; SCHEMBL3251183; CHEMBL3707403; SSR-149744C; SB17436; SSR-149744; 5-Benzofurancarboxylic acid, 2-butyl-3-(4-(3-(dibutylamino)propyl)benzoyl)-, 1-methylethyl ester
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Ventricular arrhythmias [ICD-11: BC71; ICD-10: I49, I49.8; ICD-9: 427.1] | Phase 2/3 | [1] | |
| Company |
Sanofi-aventis
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C34H47NO4
|
|||
| Canonical SMILES |
CCCCC1=C(C2=C(O1)C=CC(=C2)C(=O)OC(C)C)C(=O)C3=CC=C(C=C3)CCCN(CCCC)CCCC
|
|||
| InChI |
1S/C34H47NO4/c1-6-9-14-31-32(29-24-28(19-20-30(29)39-31)34(37)38-25(4)5)33(36)27-17-15-26(16-18-27)13-12-23-35(21-10-7-2)22-11-8-3/h15-20,24-25H,6-14,21-23H2,1-5H3
|
|||
| InChIKey |
ZCENNVQCOZQSGH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 401925-43-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00233441) Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.